AIDS Weekly articles from February 1994

AIDS Weekly archives from February 1994

Study: AZT can help newborns. (U.S. National Institutes of Health)
February 28, 1994... U.S. NIH The number of babies born with HIV could be cut in half in the next year, if public health officials can move quickly to implement the findings of a new federal study, a top researcher said. The U.S. National Institutes...

First recombinant vaccine that expresses multiple HIV proteins to be tested. (Therion Biologics Corporation)(Massachusetts)
February 28, 1994... Massachusetts Therion Biologics Corporation, Cambridge, Massachusetts, announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) is beginning a Phase I clinical trial with the company's candidate AIDS...

CD4 count may not accurately reflect disease status. (AIDS Clinical Trials Group)
February 28, 1994... AIDS Clinical Trials Group Variations in CD4 cell counts in HIV-positive, asymptomatic patients were variable enough to call into question their utility as measures of disease status, a team of researchers reports ("Within-Subject...

Addition of acyclovir useful in foscarnet-resistant HSV. (herpes simplex virus)(University of California)
February 28, 1994... University of California The addition or substitution of acyclovir to foscarnet therapy may be a useful strategy for AIDS patients with herpes simplex virus (HSV) in whom foscarnet resistance is suspected, according to a multicenter...

Immunologist named to head AIDS research programs. (William Paul)(U.S. National Institutes of Health)
February 28, 1994... U.S. NIH A prominent immunologist was named to head the U.S. National Institutes of Health's (NIH) AIDS research programs. Dr. William Paul, best known for his discovery of a key immune system molecule that is attacked by HIV,...

Universal AIDS precautions should be supplemented, surgeons say. (U.S. Centers for Disease Control and Prevention)
February 28, 1994... U.S. CDC Hospitals should use simple measures not among those required by federal law to prevent the spread of AIDS between healthcare workers and patients, according to a panel of physicians. Using blunt needles and instruments...

Country poised for AIDS epidemic. (Russia)
February 28, 1994... Russia It used to be a crime to be gay in Russia. It is legal now - but more dangerous than ever. Activists say Russia may be poised on the edge of an AIDS epidemic. "There is a sexual revolution going on. Homosexuality is...

Direct infection of organs by HIV characteristic of late disease. (Scotland)
February 28, 1994... Scotland Late in the stages of HIV disease, the organs of the patient undergo direct infection by HIV, according to a recent study ("Redistribution of HIV Outside the Lymphoid System with Onset of AIDS," Lancet, February 12,...

PWAs more vulnerable to job, insurance losses. (people with AIDS)(Maryland)
February 28, 1994... Maryland People with AIDS (PWAs) are 2.7 times more likely than seronegative people to lose their jobs and health insurance, a team of researchers reports ("Changes in Employment, Insurance and Income in Relation to HIV Status and...

KS presenting as appendicitis reported. (Kaposi's sarcoma)(Australia)
February 28, 1994... Australia Australian doctors have reported a case of Kaposi's sarcoma (KS) in an HIV-positive patient that presented as acute appendicitis ("Kaposi's Sarcoma Presenting as Acute Appendicitis in an HIV-1 Positive Patient,"...

High doses of rsCD4 lowers HIV viremia. (recombinant soluble CD4)(University of Washington and Biogen, Inc)
February 28, 1994... Washington Extremely high doses of recombinant soluble CD4 (rsCD4) inactivate cell-free HIV-1 in vivo, report researchers from the University of Washington and Biogen, Inc., ("The Effects of High-Dose Recombinant Soluble CD4 on Human...

PEG treatment of plasma enhances isolation of HIV-1. (polyethylene glycol)(Italy)
February 28, 1994... Italy Treatment of plasma with polyethylene glycol (PEG) enhanced the isolation of HIV-1 in asymptomatic and early symptomatic patients in an Italian study ("High Rate of HIV Isolation from Plasma of Asymptomatic Patients Through...

Altered cortisol secretion linked to CNS damage. (central nervous system)(New York)
February 28, 1994... New York An altered cortisol secretion may be associated with damage to the central nervous system (CNS) in HIV -infected children, New York researchers report ("Altered Cortisol Response and Hippocampal Atrophy in Pediatric HIV...

San Francisco AIDS cases peak. (California)
February 28, 1994... California The number of new AIDS cases in San Francisco, California, has peaked and should decline dramatically by 1997, health officials said. The city Department of Public Health said the annual number of new AIDS cases peaked...

New device detects microscopic holes in latex gloves and barrier garments. (Acu-Halt by EVA-Health USA, Inc)(U.S. Centers for Disease Control and Prevention)
February 28, 1994... U.S. CDC A new device designed to help lower the risks for transmission of HIV, hepatitis B and other bloodborne infections has been proven effective in instantly detecting microscopic holes in operating room gloves or barrier garments...

Toronto hospital officially opens largest HIV/AIDS clinic in Canada. (Immunodeficiency Clinic at the General Division of Toronto Hospital)(Canada)
February 28, 1994... Canada The Toronto Hospital officially opened the largest HIV/AIDS clinic in the country. The Immunodeficiency Clinic, located at the General Division of the Toronto Hospital, offers one-stop, specialty care service to...

Study confirms HIV transmission during invasive medical procedures is low. (U.S. Army)
February 28, 1994... U.S. Army Results of a U.S. military look-back investigation were consistent with current assessment that the risk of HIV transmission during invasive medical procedures is low. Jenice N. Longfield, U.S. Army Health Services...

Amino acid for HIV-1 reverse transcriptase identified. (Yale University)
February 28, 1994... Yale University The mutation at amino acid 90 of human immunodeficiency virus type 1 reverse transcriptase (HIV -1 RT) can cause cross-resistance to antiviral nucleoside triphosphate analogs and phosphonoformate, according to a report...

CPS creates InfoPack to provide treatment information. (Community Prescription Service)(New York)
February 28, 1994... New York With the publication of Community Prescription Service's new quarterly InfoPack, HIV-infected individuals now have an additional source for reliable, timely frontline treatment information. The InfoPack, which is...

Biochemist named to drug development task force. (Charles Nelson)(Georgia)(U.S. National Task Force on AIDS Drug Development)
February 28, 1994... Georgia Charles Nelson, a biochemist from Atlanta, Georgia, has been named to the U.S. National Task Force on AIDS Drug Development. The 33-year-old Nelson, who is himself HIV positive, is a researcher and volunteer with...

Seroprevalence of HCV infection in a population of patients with HIV infection. (hepatitis C virus)(Research Report)
February 28, 1994... AUTHORS: M. Coschieri, J.F. Dor, D. Quinsat, A. Philippon and E. Tocquet. CHG Antibes, Antibes, France. According to an abstract submitted by the authors to the Mediterranean Symposium on HIV Infection, held January 29, 1994, in...

Distal vascular ischemia and HIV infection: 5 cases. (Research Report)
February 28, 1994... AUTHORS: P. Pellegrino, A. Lafeuillade, I. Poizo-Martin and R. Quilichini. Hospital Chalucet, Infectious Diseases Unit, Toulon, France. According to an abstract submitted by the authors to the Mediterranean Symposium on HIV...

In vitro replication of human culture-derived macrophages. (Research Report)
February 28, 1994... AUTHORS: S.N. Breit, S.B. Por, M.A. Cooley and S. Bennett. St. Vincent's Hospital, Sydney, Australia and University of Sydney, Sydney, Australia. According to an abstract submitted by the authors to the 2nd International Workshop on...

Disruption of the HIV gp120-cellular CD4 interaction by sulphated polyanions: why are they potent inhibitors of lymphocytes but not monocytes? (Research Report) (Abstract)
February 28, 1994... AUTHORS: G. Lynch, L. Low, S. Li, F. Kazazi, J. Chang, R. Sweet, C. Parish and A. Cunningham. Westmead Hospital, Centre for Infectious Diseases and Microbiology, Westmead, NSW, Australia; SmithKline Beecham, King of Prussia, Pennsylvania;...

Molecular analysis of HIV expression in infected monocytes and macrophages: effect of cytokines. (Research Report)
February 28, 1994... AUTHORS: H. Naif, J.-M. Mathijs, M.H. Shon, J. Chang and T. Cunningham. Westmead Hospital, Virology Department, Sydney, Australia. According to an abstract submitted by the authors to the 2nd International Workshop on HIV and Cells...

HIV infection and AIDS; lentivirus-specific pitfalls of a tardive epidemic: didactic problems and psychological obstacles for prevention messages. (Research Report)
February 28, 1994... AUTHORS: M.G. Koch. Karlsborg, Sweden. According to an abstract presented by the author to the Seminar titled Education for Responsibility in Health, held November 20, 1993, in Lisbon, Portugal, "Our current concern regarding the...

Coinfection with human T-cell lymphotropic virus type-1 and HIV in Brazil - impact on markers of HIV disease progression. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Journal of the American Medical Association, February 2, 1994;271(5):353-357. According to the authors' abstract of an article published in the Journal of the American Medical Association, "Objectives: To study the effect...

Cytotoxic T-lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Vaccine, February 1994;12(2):153-158. According to the authors' abstract of an article published in Vaccine, "The host immune response of cell -mediated immunity, particularly that of cytotoxic T lymphocytes (CTLs), is a...

Epitopes recognized by HIV-SF2 Nef-specific CD4+ T-cell clones generated from HIV-1-uninfected donors. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Vaccine, February 1994;12(2):117-128. According to the authors' abstract of an article published in Vaccine, "Human T-cell clones with specificity to the HIV-1 Nef protein were generated by the in vitro stimulation of...

Endemic African Kaposi's sarcoma - clinical and therapeutic implications - 10-year experience in the Johannesburg Hospital (1980-1990). (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Oncology, January-February 1994;51(1):63-69. According to the authors' abstract of an article published in Oncology, "Endemic African Kaposi's sarcoma is a common neoplastic disorder in the sub-Saharan region of Africa. We...

Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Journal of the American Medical Association, January 26, 1994;271(4):295-301. According to the authors' abstract of an article published in the Journal of the American Medical Association, "Issue: Several investigators are...

Features of children perinatally infected with HIV-1 surviving longer than 5 years. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Lancet, January 22, 1994;343(8891):191-195. According to the authors' abstract of an article published in the Lancet, "Children infected with HIV do not necessarily develop AIDS to a set pattern but can be divided into...

Probability of female-to-male transmission of HIV-1 in Thailand. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Lancet, January 22, 1994;343(8891):204-207. According to the authors' abstract of an article published in the Lancet, "The epidemic of human immunodeficiency virus type 1 (HIV-1) infection in Thailand has allowed an...

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Science, January 21, 1994;263(5145):380-384. According to the authors' abstract of an article published in Science, "Mechanistic information and structure-based design methods have been used to design a series of nonpeptide...

Direct interaction of human TFIID with the HIV-1 transactivator Tat. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: Nature, January 20, 1994;367(6460):295-299. According to the authors' abstract of an article published in Nature, "The tat gene of the human immunodeficiency virus (HIV) plays a central role in the activation and life cycle...

Incidence of HIV-1 infection in a rural region of Uganda. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: British Medical Journal, January 15, 1994;308(6922):171-173. According to the authors' abstract of an article published in the British Medical Journal, "Objective: To determine the incidence of infection with HIV-1 and...

The questionable utility of mandatory screening for the human immunodeficiency virus. (Periodical Report) (Abstract)
February 28, 1994... SOURCE: American Journal of Surgery, December 1993;166(6):676-679. According to the authors' abstract of an article published in the American Journal of Surgery, "Trauma patients have been identified as a high-risk group for human...

Hybrid AIDS virus tested at baboon center. (Texas)
February 21, 1994... DATELINE: Texas San Antonio, Texas, scientists have successfully infected two baboons with a hybrid human-monkey AIDS virus, providing them another animal model with which an AIDS vaccine might be developed. Researchers at...

Trials in HIV patients begin. (drug trials)(Synovir)(Celgene Corporation)
February 21, 1994... DATELINE: Celgene Corporation Celgene Corporation, Warren, New Jersey, announced that it has entered into a clinical collaboration with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), of the U.S. National...

Trial of OPC-8212 to begin. (drug trial)(Georgia)
February 21, 1994... DATELINE: Georgia A clinical trial of the Japanese drug, OPC-8212, will begin in Atlanta, Georgia, in February 1994. The drug, manufactured by Otsuka America Pharmaceuticals, inhibits substances associated with the replication of...

Pharmaceutical companies reinforce partnership to combat AIDS. (World Health Organization)
February 21, 1994... DATELINE: WHO Research based pharmaceutical companies represented by the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) have agreed to work with the World Health Organization (WHO) in the effort to...

BioChem Pharma and Glaxo extend research agreement. (British Columbia)
February 21, 1994... DATELINE: British Columbia BioChem Pharma Inc. and Glaxo Canada Inc. signed a letter of intent extending their Research Agreement in the antiviral field for a two-year period. The Agreement remains in effect until December 31, 1996,...

Recently discovered bacterial disease linked to cats. (bacillary angiomatosis caused by Rochalimaea henselae)(University of California, San Francisco)
February 21, 1994... DATELINE: University of California, San Francisco Stressing they do not suggest that people avoid cats, researchers at University of California, San Francisco (UCSF), say that some patients with a rare and recently recognized bacterial...

Syntello acquires broad rights to mucosal vaccine. (cholera toxin B mucosal vaccine carrier)(California)
February 21, 1994... DATELINE: California Syntello Inc., San Diego, California, has acquired exclusive rights to apply and license the Cholera Toxin B (CTB) mucosal vaccine carrier, developed by Dr. Jan Holmgren at the University of Gothenburg, Sweden....

Company awarded $750,000 NIH grant for antifungal drug research. (Myco Pharmaceuticals Inc.;National Institutes of Health)(Massachusetts)
February 21, 1994... DATELINE: Massachusetts Myco Pharmaceuticals Inc. announced that the company and its collaborators have been awarded by the U.S. National Institutes of Health (NIH) a grant for over $750,000 to fund antifungal drug research. The grant,...

Plasma immunotherapy affected by presence of p24 antibody. (California)
February 21, 1994... DATELINE: California The potential benefits of plasma immunotherapy in the treatment of pediatric AIDS may depend on specific p24 antibody, according to a recent report ("Plasma Immunotherapy in a Child with Acquired Immunodeficiency...

Transfusions to HIV-infected patients results in increased death rate. (U.S. National Heart, Lung and Blood Institute)
February 21, 1994... DATELINE: U.S. National Heart, Lung and Blood Institute HIV-infected patients who received transfusions showed increased incidence of cytomegalovirus (CMV) infection and increased death rate, stated researchers from the U.S. National...

Researchers report good results in CMV retinitis study. (cytomegalovirus retinitis)(Scotland)
February 21, 1994... DATELINE: Scotland Researchers from Edinburgh, Scotland, report that, with prompt diagnosis and treatment, the vision of most patients with cytomegalovirus retinitis (CMVR) can be preserved ("Cytomegalovirus Retinitis and AIDS in...

Preventive treatment reduces toxoplasmosis in HIV-infected patients. (University of California, San Francisco)
February 21, 1994... DATELINE: University of California, San Francisco A study directed by University of California, San Francisco (UCSF), researchers has found that HIV-infected patients taking preventive treatment with the drug...

HSV-1 and HIV-1 enhance each other's replication. (herpes simplex virus type 1)
February 21, 1994... DATELINE: California Herpes simplex virus type 1 (HSV-1) and HIV-1 each reciprocally enhance the other's viral replication when both are present in patients with AIDS, according to a report from California researchers ("Co-infection...

Persistent diarrhea associated with HIV disease progression. (in infants)(University of Maryland)
February 21, 1994... DATELINE: University of Maryland Persistent diarrhea in HIV-infected infants is a marker for more rapid progression of disease, according to a recent report ("Diarrheal Morbidity during the First Two Years of Life among HIV-Infected...

Severity of mother's disease determines progress of offspring's HIV. (France)
February 21, 1994... DATELINE: France The rate of progression of HIV disease in perinatally infected infants varies directly with the severity of their mother's disease at the time of delivery, French researchers report ("Relation of the Course of HIV...

Study finds high rate of HIV infection among inner-city alcoholics. (University of California, San Francisco)
February 21, 1994... DATELINE: University of California, San Francisco University of California, San Francisco (UCSF), researchers have found a much higher than expected rate of HIV infection among inner-city heterosexual alcoholics whose main risk factor...

Experts sound alarm on worldwide resurgence of tuberculosis. (Washington, D.C.)
February 21, 1994... DATELINE: Washington, D.C. Healthcare experts told the U.S. Congress about the resurgence of tuberculosis (TB) in the United States as part of a worldwide "stealth epidemic" that might cause 30 million deaths in the next decade. ...

Five charged for selling blood plasma not tested for HIV. (Germany)
February 21, 1994... DATELINE: Germany German prosecutors said they have charged five people with selling blood plasma improperly tested for HIV. The five employees of the now-closed UB-Plasma Company in Koblenz, Germany, are accused of pooling blood...

Council committee urges easing on marijuana laws. (San Diego)(California)
February 21, 1994... DATELINE: California A San Diego, California, council committee unanimously voted to urge President Clinton and Congress to end federal restrictions against the use of marijuana for "legitimate medical use." City councilwoman...

Majority of TB cases not associated with HIV/AIDS, study says. (tuberculosis)(Texas)
February 21, 1994... DATELINE: Texas Texas physicians are encountering increasing numbers of cases of tuberculosis (TB) that are not the result of opportunistic HIV/AIDS infections, a researcher said in a poster presentation at the annual meeting of the...

Man charged with changing HIV test. (New York)
February 21, 1994... DATELINE: New York A supervisor with the New York City Department of Health has been charged with changing the confidential result of a HIV test from positive to negative. A 35-year-old man of Manhattan, New York, was charged with...

Tat-mediated activation of an ISRE containing HIV-1 LTR and its potential use for IFN gene therapy. (IFN-stimulated response element)(long terminal repeat)(Research Report)
February 21, 1994... AUTHORS: P.M. Pitha and Y. Su. Johns Hopkins University, Oncology Center, Baltimore, Maryland. According to an abstract submitted by the authors to the Conference on Gene Therapy, held January 15-22, 1994, in Copper Mountain,...

Promoter for expression of transduced anti-HIV and SIV ribozymes. (Research Report)
February 21, 1994... AUTHORS: J.J. Rossi 1, C. Carbonnelle 1, S. Li 2, S. Chatterjee 2, J.A. Zaia 2 G. Larson 1 and E. Bertrand 1. 1Department of Molecular Genetics, Beckman Research Institute, Duarte, California; 2Division of Pediatrics, City of Hope National...

Differences in participation in clinical trials among persons with AIDS. (Research Report)
February 21, 1994... AUTHORS: T. Diaz and S.Y. Chu. U.S. Centers for Disease Control and Prevention, Atlanta, Georgia. According to an abstract presented by the authors to the First National Conference on Human Retroviruses and Related Infections, held...

Racial differences in the risk of AIDS among infants and women in the United States from 1987 to 1990. (Research Report)
February 21, 1994... AUTHORS: Z.R. Ding, Q. Li and L. Ding. University of Maryland, Baltimore, Maryland; U.S. National Institutes of Health, Bethesda, Maryland; Anti-Epidemic Center of Guangxi, Nanning, Guangxi, China. According to an abstract presented...

AIDS trends among women and infants and strategy of prevention. (Research Report)
February 21, 1994... AUTHORS: Z.R. Ding, Q.Li and L. Ding. Anti-Epidemic Center of Guangxi, Nanning, Guangxi, China; University of Maryland, School of Medicine, Baltimore, Maryland; and U.S. National Institutes of Health, Bethesda, Maryland. According to...

Molecular analysis of the HIV-1 gp120 from paired mother-child samples. (Research Report)
February 21, 1994... AUTHORS: W.W. Roth, J.A. Zuberi, P. Whitley-Williams and S.K. Davidson. Morehouse University, School of Medicine, Atlanta, Georgia. According to an abstract presented by the authors to the First National Conference on Human...

Stimulation of leukocyte adhesions by HIV-1. (Research Report)
February 21, 1994... AUTHORS: R.D. Rossen, J.A. Trial, S.C. Smole, H.H. Birdsall, A.H. Laughter, F.M. Orson, J.W. Harper and C.G. Figdor. Veterans Affairs Medical Center, Houston, Texas, and Baylor University, College of Medicine, Houston, Texas. ...

Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in the restriction of virus replication. (Research Report)
February 21, 1994... AUTHORS: S. Gessani, P. Puddu, B. Varano, P. Borghi, L. Conti, L. Fantuzzi and F. Belardelli. Istituto Superiore di Sanita, Rome, Italy. According to an abstract submitted by the authors to the 2nd International Workshop on HIV and...

Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Annals of Internal Medicine, January 15, 1994;120(2):118-125. According to the authors' abstract of an article published in Annals of Internal Medicine, "Objective: To describe 13 infections caused by Mycobacterium...

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Nature, January 13, 1994;367(6459):188-193. According to the authors' abstract of an article published in Nature, "Many people infected with human immunodeficiency virus type 1 (HIV-1) develop neurological complications...

Continuity and change within an HIV epidemic - injecting drug users in New York City, 1984 through 1992. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Journal of the American Medical Association, January 12, 1994;271(2):121-127. According to the authors' abstract of an article published in the Journal of the American Medical Association, "Objectives: To examine trends in...

Syringe and needle exchange as HIV/AIDS prevention for injection drug users. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Journal of the American Medical Association, January 12, 1994;271(2):115-120. According to the authors' abstract of an article published in the Journal of the American Medical Association, "Objective: To evaluate an...

Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin-6 in chronically infected U1 cells - inhibition of inductive effects by the interleukin-1 receptor antagonist. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, January 4, 1994;91(1):108-112. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences...

Immune system-central nervous system interactions - effect and immunomodulatory consequences of immune system mediators on the brain. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Antimicrobial Agents and Chemotherapy, January 1994;38(1):7-12. According to the author's abstract of an article published in Antimicrobial Agents and Chemotherapy, "A bidirectional circuit exists between the central...

The risk of blood splash contamination during angiography. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Clinical Radiology, January 1994;49(1):59-60. According to the authors' abstract of an article published in Clinical Radiology, "Blood splash contamination of the conjunctivae or buccal mucosa may occur during angiography...

Recombinant virus assay - a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type-1 isolates. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Antimicrobial Agents and Chemotherapy, January 1994;38(1):23-30. According to the authors' abstract of an article published in Antimicrobial Agents and Chemotherapy, "Antiviral drug susceptibility assays for clinical human...

Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. (Periodical Report) (Abstract)
February 21, 1994... SOURCE: Journal of Acquired Immune Deficiency Syndromes, January 1994;7(1):68-73. According to the authors' abstract of an article published in the Journal of Acquired Immune Deficiency Syndromes, "Breast milk specimens from human...

President names panel to speed search for HIV drug. (Bill Clinton) (Washington, D.C.)
February 14, 1994... Washington, D.C. The Clinton administration named an 18-member panel of scientists, doctors and AIDS activists to help speed the search for new drugs to combat HIV. The panel includes pharmaceutical industry executives as well as...

Thousands rally in London to lower the age of consent for gays. (United Kingdom)
February 14, 1994... United Kingdom Thousands gathered in London's Trafalgar Square to demonstrate their support for lowering the age of consent for homosexual men in Britain from 21 to 16. During the last few weeks, gay rights campaigners and medical...

Survey finds national differences in condom use. (Europe)
February 14, 1994... Europe A survey released in Paris, France, February 3, 1994, reveals national differences in condom use among European men. For instance, Spanish men used an average of 3.8 condoms each in 1992, as compared with 2.7 used by...

Trials of the first globally targeted AIDS vaccine begin. (United Biomedical Inc.)
February 14, 1994... United Biomedical Inc. United Biomedical Inc. (UBI), Hauppauge, New York, has begun clinical trials of the first multicomponent synthetic AIDS vaccine designed specifically to address the extensive worldwide variability of HIV-1. ...

Zidovudine resistance persists after therapy discontinued. (University of North Carolina)
February 14, 1994... University of North Carolina A report from a North Carolina research facility suggests that zidovudine-resistant HIV appears to persist and replicate well in vivo after discontinuation of zidovudine therapy. The emergence of...

Combined zidovudine/didanosine shows enhanced activity. (U.S. National Cancer Institute)
February 14, 1994... U.S. NCI Simultaneous therapy with zidovudine and didanosine (ddI) provided more sustained elevations in CD4 cells than alternating therapy with the agents over a one-year period, according to a report from the U.S. National Cancer...

HIV immune responses in exposed healthcare workers studied. (U.S. National Institutes of Health)
February 14, 1994... U.S. NIH Exposure to HIV with no evidence of subsequent infection appears to result in activation of cellular immunity without activation of antibody production, concluded researchers from the U.S. National Institutes of Health (NIH),...

Conference set to explore diagnosis and management of TB. (tuberculosis) (New York)
February 14, 1994... New York Physicians, scientists and government and public health officials will explore potential solutions to diagnosing and managing tuberculosis (TB) during a special conference scheduled March 1, 1994. The conference will be...

Condom use varies depending on nature of relationship. (United Kingdom)
February 14, 1994... United Kingdom British researchers found an overall increase in condom use among gay and bisexual men over time, but noted significant differences depending on the nature of the partner, whether casual or regular ("Changes in Condom...